People in Japan carry an omega-3 index around 9 to 11 percent. People in the United States hover near 4 to 5 percent. That gap, more than almost any dietary variable you can name, mirrors the gap in heart disease death rates between the two countries. It is not proof of cause. But it is the kind of clue that makes you want the number in your own file.
The omega-3 index measures the proportion of EPA and DHA, the two long-chain marine fats, in the membranes of your red blood cells. Not your plasma, which swings with whatever you ate yesterday. Red cells live about four months, so the index reflects your average marine fat intake over the previous several weeks. It is a slow, honest number, closer to HbA1c than to a fasting glucose.
Why membranes care about fat you ate
Every cell you own is wrapped in a bilayer of fat, and the composition of that fat is not fixed. It shifts to reflect what arrives in your bloodstream. Swap in more EPA and DHA and the membrane becomes more fluid, which changes how ion channels behave, how cells signal, and how prone the heart is to the chaotic electrical rhythms that cause sudden cardiac death. DHA in particular concentrates in cardiac and neural tissue for a reason.
These fats also feed the resolution phase of inflammation. EPA and DHA are the raw material for resolvins and protectins, molecules that actively switch inflammation off rather than just failing to turn it on. That is a different job from an anti-inflammatory drug, which mostly blocks the ignition.
What counts as a good number
William Harris, who developed the index, proposed that below 4 percent puts you in the highest-risk band and above 8 percent in the lowest. Most Western adults land in the murky middle.
| Omega-3 index | Category | Rough population |
|---|---|---|
| Below 4% | Undesirable, highest cardiac risk | Typical US adult eating little fish |
| 4% to 8% | Intermediate | Most Western adults |
| Above 8% | Desirable, lowest risk | Regular oily-fish eaters, coastal Japan |
These are association-based thresholds drawn from observational cohorts, not a number a trial randomized people to. Hold them loosely. But the direction is consistent across studies: higher red-cell omega-3 tracks with lower total mortality and fewer fatal heart events.
The trials that muddied everything, then unmuddied it
Fish oil has a confusing evidence trail, and it is worth knowing why. Two large, careful trials of 1 gram a day of ordinary fish oil came up mostly empty. VITAL gave roughly 25,000 healthy adults 1 gram daily and found no significant drop in the primary composite of major cardiovascular events, though heart attacks specifically fell NEJM, 2019. ASCEND tested the same dose in people with diabetes and found no benefit on its primary endpoint NEJM, 2018. If you stopped reading there, you would conclude fish oil does nothing.
Then came REDUCE-IT, which used a purified high-dose EPA product at 4 grams a day in people with high triglycerides already on statins. It cut major cardiovascular events by about 25 percent NEJM, 2019. Four times the dose, a different formulation, a higher-risk population, a real result.
The most likely reconciliation is dose. One gram a day barely moves the omega-3 index in someone starting low. Four grams moves it substantially. The trials that worked pushed membrane levels into a range the low-dose trials never reached. This is exactly why measuring the index matters more than counting capsules. The capsule count is the input. The index is the thing that actually changes biology, and people absorb and incorporate these fats at wildly different rates.
What to do about it on Monday
Ask for the test by name. Most standard lipid panels and physicals do not include it, and many labs offer it as a finger-prick kit you can order without a doctor. Get a baseline before you change anything.
If you eat two or three servings of oily fish a week, salmon, sardines, mackerel, herring, you may already be near 8 percent and need nothing else. If you rarely eat fish, a low index is close to a certainty. To raise it, food beats pills for absorption, but a supplement is fine. Look at the actual EPA plus DHA on the label, not the total fish oil weight. A 1,000 mg capsule often contains only 300 mg of the fats that count. Take it with a meal containing fat, because these are fat-soluble and absorption roughly doubles alongside food.
Retest in three to four months. That is one red-cell lifespan, long enough for the membrane to reflect your new intake. Adjust the dose to hit target rather than guessing.
If you are managing cardiovascular risk more broadly, the index sits alongside the other levers worth pulling, including strength training after 40 and the metabolic picture a CGM reveals that bloodwork misses.
Where the evidence thins out
The omega-3 index is a strong marker of association, not a validated treatment target with its own outcome trial. Nobody has randomized people to a specific index and followed hard endpoints. High-dose EPA helped a high-risk, high-triglyceride population, and it would be a stretch to assume a healthy 40-year-old with a good diet gets the same 25 percent.
There is also an inconvenient signal worth naming: some high-dose omega-3 trials found a small increase in atrial fibrillation. If you have a history of AF, talk to a cardiologist before loading up. And the fish-versus-capsule question is not fully settled, because oily fish delivers protein, selenium, and vitamin D that no softgel contains. The number tells you where you stand. It does not tell you the whole story of how you got there.